Long-term outcome of mixed chimerism after stem cell transplantation for thalassemia major conditioned with busulfan and cyclophosphamide-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term outcome of mixed chimerism after stem cell transplantation for thalassemia major conditioned with busulfan and cyclophosphamide

Published:2017-10-16 Issue:2 Volume:53 Page:169-174
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Fouzia N A,Edison E S,Lakshmi K M,Korula A,Velayudhan S R,Balasubramanian P,Abraham A,Viswabandya A,George B,Mathews V,Srivastava A

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2017231.pdf

Reference22 articles.

1. Andreani M, Testi M, Gaziev J, Condello R, Bontadini A, Tazzari PL et al. Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease. Haematologica 2011; 96: 128–133.

2. Andreani M, Testi M, Lucarelli G . Mixed chimerism in haemoglobinopathies: from risk of graft rejection to immune tolerance: persistent mixed chimerism and immune tolerance. Tissue Antigens 2014; 83: 137–146.

3. Angelucci E, Baronciani D . Allogeneic stem cell transplantation for thalassemia major. Haematologica 2008; 93: 1780–1784.

4. Hsieh MM, Wu CJ, Tisdale JF . In mixed hematopoietic chimerism, the donor red cells win. Haematologica 2011; 96: 13–15.

5. Hsieh MM, Wu CJ, Tisdale JF . In mixed hematopoietic chimerism, the donor red cells win. Haematologica 2011; 96: 13–15.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uniform graft-versus-host disease prophylaxis using post-transplantation cyclophosphamide, methotrexate, and cyclosporine following peripheral blood hematopoietic stem cell transplantation from matched and haploidentical donors for transfusion-dependent thalassemia: a retrospective report from the BMF-WG of Hunan province, China;Transplantation and Cellular Therapy;2024-09

2. Prospects and Potential for Chimerism Analysis after Allogeneic Hematopoietic Stem Cell Transplantation;Cells;2024-06-06

3. Good engraftment after reduced intensity targeted busulfan‐based conditioning and matched related donor hematopoietic cell transplantation in hemoglobinopathies;Pediatric Blood & Cancer;2024-04-12

4. Treatment of Mixed Chimerism After Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Major;American Journal of Pediatrics;2024-02-20

5. Treosulfan Exposure Predicts Thalassemia‐Free Survival in Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Cell Transplantation;Clinical Pharmacology & Therapeutics;2023-11-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3